Somaiya Mayur Ian Insider Trades

Insider Trading History

Track insider trading activity for Somaiya Mayur Ian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $2.65M 82,744 shares
Last Trade
Jan 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.34M 39,784 shares
$33.59
$31.98
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $3.14M 98,166 shares
Last Trade
Jan 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.35M 39,784 shares
$33.94
$31.98
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $2.02M 98,166 shares
Last Trade
Jan 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$875k 39,784 shares
$22.00
$20.56
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $1.7M 82,744 shares
Last Trade
Jan 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$875k 39,784 shares
$22.00
$20.56
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $13.6M 662,814 shares
Last Trade
Jan 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$875k 39,784 shares
$22.00
$20.56
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $21.2M 662,814 shares
Last Trade
Jan 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.35M 39,784 shares
$33.94
$31.98
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $22.5M 702,598 shares
Last Trade
Jan 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.95M 60,216 shares
$32.41
$31.98
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $2.42M 117,698 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.25M 60,216 shares
$20.82
$20.56
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $3.76M 117,698 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.92M 60,216 shares
$31.96
$31.98
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $2.44M 118,598 shares
Last Trade
Jan 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.25M 60,216 shares
$20.82
$20.56
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $14.4M 702,598 shares
Last Trade
Jan 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.25M 60,216 shares
$20.82
$20.56
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $3.79M 118,598 shares
Last Trade
Jan 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.95M 60,216 shares
$32.41
$31.98
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $2.36M 115,000 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.25M 140,500 shares
$23.10
$20.56
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $3.68M 115,000 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.98M 140,500 shares
$35.45
$31.98
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $676k 32,882 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$118k 5,118 shares
$23.10
$20.56
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $1.05M 32,882 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$170k 5,118 shares
$33.25
$31.98
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $24.4M 762,814 shares
Last Trade
Jan 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 14,900 shares
$21.45
$31.98
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $1.32M 41,405 shares
Last Trade
Jan 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$315k 14,900 shares
$21.16
$31.98
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Financial Officer
Holding Value $1.69M 52,900 shares
Last Trade
Jan 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 14,900 shares
$21.45
$31.98
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Financial Officer
Holding Value $15.7M 762,814 shares
Last Trade
Jan 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$138k 14,900 shares
$9.26
$20.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up